KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,388 | -31.3% | 19,884 | +13.7% | 0.00% | – |
| Q2 2023 | $402,187 | -46.1% | 17,494 | -30.6% | 0.00% | – |
| Q1 2023 | $746,705 | +42.6% | 25,201 | +20.1% | 0.00% | – |
| Q4 2022 | $523,686 | +50.5% | 20,981 | +31.3% | 0.00% | – |
| Q3 2022 | $348,000 | -12.3% | 15,976 | -20.8% | 0.00% | – |
| Q2 2022 | $397,000 | -71.9% | 20,176 | -39.5% | 0.00% | -100.0% |
| Q1 2022 | $1,412,000 | -37.3% | 33,366 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $2,251,000 | +7.6% | 35,450 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $2,092,000 | +125.9% | 35,619 | +86.5% | 0.00% | – |
| Q2 2021 | $926,000 | +250.8% | 19,100 | +181.0% | 0.00% | – |
| Q1 2021 | $264,000 | -42.6% | 6,798 | -8.3% | 0.00% | – |
| Q4 2020 | $460,000 | – | 7,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |